Literature DB >> 12771000

Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.

Eric M Wilson1, Sina L Moainie, Julia M Baskin, Abigail S Lowry, Anne M Deschamps, Rupak Mukherjee, T Sloane Guy, Martin G St John-Sutton, Joseph H Gorman, L Henry Edmunds, Robert C Gorman, Francis G Spinale.   

Abstract

BACKGROUND: Induction of matrix metalloproteinases (MMPs) contributes to adverse remodeling after myocardial infarction (MI). Whether a region- and type-specific distribution of MMPs occurs within the post-MI myocardium remained unknown. METHODS AND
RESULTS: Ten sheep were instrumented with a sonomicrometry array to measure dimensions in 7 distinct regions corresponding to the remote, transition, and MI regions. Eight sheep served as reference controls. The relative abundance of representative MMP types and the tissue inhibitors of the MMPs (TIMPs) was quantified by immunoblotting. Segment length increased from baseline in the remote (24.9+/-5.4%), transition (18.0+/-2.9%), and MI (53.8+/-11.0%) regions at 8 weeks after MI (P<0.05) and was greatest in the MI region (P<0.05). Region- and type-specific changes in MMPs occurred after MI. For example, MMP-1 and MMP-9 abundance was unchanged in the remote, fell to 3+/-2% in the transition, and was undetectable in the MI region (P<0.05). MMP-13, MMP-8, and MT1-MMP increased by >300% in the transition and MI regions (P<0.05). TIMP abundance decreased significantly in the transition region after MI and fell to undetectable levels within the MI region.
CONCLUSIONS: The unique findings of this study were 2-fold. First, changes in regional geometry after MI were associated with changes in MMP levels. Second, a region-specific portfolio of MMPs was induced after MI and was accompanied by a decline in TIMP levels, indicative of a loss of MMP inhibitory control. Targeting the regional imbalance between specific MMPs and TIMPs within the post-MI myocardium holds therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771000     DOI: 10.1161/01.CIR.0000068375.40887.FA

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  79 in total

1.  Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.

Authors:  Rupak Mukherjee; Gregory P Colbath; Charles D Justus; James A Bruce; Claire M Allen; Kenneth W Hewett; J Philip Saul; Robert G Gourdie; Francis G Spinale
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.

Authors:  Francis G Spinale; Rupak Mukherjee; Juozas A Zavadzkas; Christine N Koval; Shenikqua Bouges; Robert E Stroud; Lawrence W Dobrucki; Albert J Sinusas
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

4.  Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction.

Authors:  Sandro Goruppi; Richard D Patten; Thomas Force; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 5.  Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.

Authors:  Keyur B Shah; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2004-12

6.  Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.

Authors:  Shaina R Eckhouse; Brendan P Purcell; Jeremy R McGarvey; David Lobb; Christina B Logdon; Heather Doviak; Jason W O'Neill; James A Shuman; Craig P Novack; Kia N Zellars; Sara Pettaway; Roy A Black; Aarif Khakoo; Taeweon Lee; Rupak Mukherjee; Joseph H Gorman; Robert C Gorman; Jason A Burdick; Francis G Spinale
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  Heterogeneity of left ventricular wall thickening mechanisms.

Authors:  Allen Cheng; Tom C Nguyen; Marcin Malinowski; George T Daughters; D Craig Miller; Neil B Ingels
Journal:  Circulation       Date:  2008-07-28       Impact factor: 29.690

8.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

9.  Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).

Authors:  D Dirk Bonnema; Carson S Webb; Weems R Pennington; Robert E Stroud; Amy E Leonardi; Leslie L Clark; Catherine D McClure; Laura Finklea; Francis G Spinale; Michael R Zile
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

10.  Alterations in transmural myocardial strain: an early marker of left ventricular dysfunction in mitral regurgitation?

Authors:  Carl J Carlhäll; Tom C Nguyen; Akinobu Itoh; Daniel B Ennis; Wolfgang Bothe; David Liang; Neil B Ingels; D Craig Miller
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.